Protocol Name: Phase 2 Study of Lorundrostat Alone or in Combination with Dapagliflozin in adults with HTN and CKD with Albuminuria
Sponsor: Mineralys
Indication: Chronic Kidney Disease (CKD)
Principal Investigator: Kim Rice, MD
Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246